Skip to content

Validation of the 1-minute Sit-to-stand Test in Patients With COPD

1-minute Sit-to-stand Test: A Multicentre Validation Study of a Simple Exercise Capacity Test in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02441725
Acronym
STAND-UP
Enrollment
55
Registered
2015-05-12
Start date
2015-04-30
Completion date
2016-05-31
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

This is a study to provide an in-depth validation of the 1-minute sit-to-stand test as a measure of exercise capacity in patients with chronic obstructive pulmonary disease (COPD). Patients will perform the 1-minute sit-to-stand test and other validated exercise tests and questionnaires.

Detailed description

Exercise capacity is a strong predictor for mortality, exacerbations and health-related quality of life (HRQL) in patients with chronic obstructive pulmonary disease (COPD). The 1-minute sit-to-stand test (1-min STS test) is a promising exercise capacity test that is simple to conduct and requires few resources. This study will provide an in-depth validation of the 1-min STS test, specifically evaluating the tests reliability, validity, responsiveness to change and minimal clinically important difference. The study will also assess the predictive properties of the 1-min STS test with regards to detecting exacerbations, as well as identify patterns of physical activity and patient-reported symptoms of exacerbations.

Interventions

Validation of the 1-minute sit-to-stand test in a COPD patient population

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD diagnosis according to GOLD criteria; post bronchodilator FEV1/FVC\<70% * Male and female patients ≥40 years of age * Able to do at least 5 repetitions in the 1-min STS test at baseline assessment * Written informed consent by the participant

Exclusion criteria

* Lower limb joint surgery in the preceding 3 months * Too unstable medically to perform exercise tests * Predominant neurological or musculoskeletal limitation to walking * Cognitive reading impairment and/or difficulties managing the eDiary and step-counter

Design outcomes

Primary

MeasureTime frameDescription
1-minute sit-to-stand testChange from baseline after pulmonary rehabilitation programmeNumber of repetitions performed in the 1-minute sit-to-stand test

Secondary

MeasureTime frameDescription
Heart RateChange from baseline (pre-exercise test) during and after test
6-minute walk testChange from baseline after pulmonary rehabilitation programmeDistance walked in 6 minutes
Respiratory exchange ratio (RER)Change from baseline (pre-exercise test) during and after test
5-repetition sit-to-stand testChange from baseline after pulmonary rehabilitation programmeTime taken to perform 5 sit-to-stand repetitions
Quadriceps maximal voluntary contraction forceChange from baseline after pulmonary rehabilitation programme
Chronic Respiratory QuestionnaireChange from baseline after pulmonary rehabilitation programme
Hospital Anxiety and Depression ScaleChange from baseline after pulmonary rehabilitation programme
COPD Assessment TestChange from Baseline after pulmonary rehabilitation programme
Minute ventilation (VE)Change from baseline (pre-exercise test) during and after test
Feeling ThermometerChange from baseline after pulmonary rehabilitation programme
Oxygen consumption (VO2)Change from baseline (pre-exercise test) during and after test
Carbon dioxide production (VCO2)Change from baseline (pre-exercise test) during and after test
Blood oxygen saturationChange from baseline (pre-exercise test) during and after test
Symptoms of exacerbationsDaily course over 3 monthsThe EXAcerbations of Chronic Pulmonary Disease Tool (EXACT)
Physical activityDaily course over 3 monthsAs measured by a pedometer
LocalisationDaily course over 3 monthsAs measured by GPS information
Baseline Dyspnoea & Transition Dyspnoea IndexChange from baseline after pulmonary rehabilitation programme

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026